Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF December 18, 2015 | Archived Issues

Next Issue Will Publish Jan. 15

Because of the holiday, Medical Staff Pulse and will not publish on Friday, Jan. 1. The next issue of Pulse will come out on Jan. 15.


FDA Warns About SGLT2 Inhibitors, Contrast Media

Pharmacy Focus

A review by the U.S. Food and Drug Administration has resulted in additional warnings on the labels of sodium-glucose cotransporter-2 (SGLT2) inhibitors about the risks of too much acid in the blood and of serious urinary tract infections. Also, the FDA is advising that rare cases of underactive thyroid have been reported in infants following the use of contrast media containing iodine for X-rays and other medical imaging procedures. 

» Read more


Meetings and Events


Grand Rounds

Click here to view upcoming grand rounds.


Upcoming CME Conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - December 2015 (PDF)  


Milestones

George Diamond, MD, has died.

» Read more

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

Getting Smarter About Antibiotics

In an effort to enhance patient safety and quality outcomes, Cedars-Sinai is promoting extra measures regarding the effective use of antibiotics.

The Antimicrobial Stewardship team recently implemented best practice alerts in CS-Link™ in several pilot units for patients receiving selected antibiotics for three or more days.

"What this three-day alert does is allow providers an opportunity to reassess the prescription of antibiotics and evaluate if further treatment is needed," said Rita Shane, PharmD, chief pharmacy officer. "This supports our efforts to reduce overuse of antibiotics and antibiotic resistance."

The federal Centers for Disease Control and Prevention (CDC) estimates that at least 2 million illnesses and deaths are caused by antibiotic-resistant bacteria in the United States, and up to 50 percent of antibiotics are unnecessary or inappropriate as prescribed.

"To be effective in our prescription of antibiotics, it is important to select the right antibiotic regimen based on indication, modify therapy based on culture and susceptibility results, and discontinue therapy when it is no longer indicated," said Rekha Murthy, MD, director of Hospital Epidemiology. "We owe it to our patients to take this pause, assess treatment and make any changes in the regimen that are needed."

Antibiotic-resistant infections typically occur in healthcare settings and spread quickly among patients with compromised immune systems. Incorrect use of antibiotics can cause increased hospitalizations, lengths of stay and risks of death.

"The way we use antibiotics today in one patient can have a profound effect on how effective antibiotic use is in future patients," Shane said. "Taking an antibiotic timeout when a patient's culture comes back is a critical patient safety step against development of resistant bacteria and other consequences, such as C. difficile infection or drug-related adverse events."

At Cedars-Sinai, healthcare providers are being asked to prescribe the right antibiotic at the right dose at the right time. They also are being encouraged to better educate patients on the appropriate use of antibiotics.

For more information on safe and effective use of antibiotics, visit the CDC's website.